Collecting blood samples from prostate cancer patients
Collection of Blood From Patients With Prostate Cancer
This study is collecting blood samples from men with prostate cancer to see if genetic differences affect how the disease progresses.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | National Institutes of Health Clinical Center (CC) NIH |
| Locations | 1 site (Bethesda, Maryland) |
| Trial ID | NCT00923221 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect blood samples from patients diagnosed with prostate cancer to investigate genetic differences that may influence the progression to an androgen-independent state. Participants will be evaluated at the NCI Medical Oncology Clinic, where blood samples will be taken during initial or follow-up visits. The study focuses on extracting genomic DNA and white blood cells for genotyping analyses, correlating genetic variance with prostate cancer prognosis and other prognostic indicators.
Who should consider this trial
Good fit: Ideal candidates for this study are adult men aged 18 and older who have been diagnosed with prostate cancer.
Not a fit: Patients who do not have a diagnosis of prostate cancer or are under 18 years old will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of genetic factors influencing prostate cancer progression, potentially leading to improved treatment strategies.
How similar studies have performed: Other studies have shown success in identifying genetic markers associated with cancer progression, suggesting that this approach may yield valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
* INCLUSION CRITERIA: Individuals 18 years of age and older are eligible. Individuals with a diagnosis of prostate cancer are eligible. EXCLUSION CRITERIA: Children are not eligible.
Where this trial is running
Bethesda, Maryland
- National Institutes of Health Clinical Center — Bethesda, Maryland, United States (Recruiting)
Study contacts
- Principal investigator: William D Figg, Pharm.D. — National Cancer Institute (NCI)
- Study coordinator: Paula A Carter, R.N.
- Email: pcartera@mail.nih.gov
- Phone: (240) 858-3191
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.